Actively Recruiting
Gii'Igoshimong: Sitting With Your First Family
Led by Johns Hopkins Bloomberg School of Public Health · Updated on 2026-03-31
300
Participants Needed
1
Research Sites
194 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this randomized wait-list control study is to understand the relationship between ceremony and substance use (SU), SU risk (e.g., SU severity, depressive symptoms) and protective factors (e.g., spirituality, community support). The main questions it aims to answer are: * Will adults enrolled in Gii'igoshimong show improved SU outcomes compared to those in control groups? * Will self-relevant processing networks activated during stimulus engagement increase from pre- to post- engagement in ceremony and at 6-month follow-up? Researchers will compare adults that complete Gii'igoshimong with those that do not complete Gii'igoshimong to see if health outcomes are different. After completing baseline assessments, participants will be randomized to complete Gii'igoshimong now (intervention) or after the participants have completed the 1 month and 6-month post assessments (waitlist control). All participants (intervention and waitlist control) within a cohort will complete 1 month and 6 month post assessments at the same time.
CONDITIONS
Official Title
Gii'Igoshimong: Sitting With Your First Family
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Are 18 years of age or older
- Self-identify as Ojibwe/Anishinaabe/Chippewa
- Self-report using any kind of substances in the past 30 days
- Have no history of head injury with loss of consciousness
- Do not have a seizure disorder
- Do not currently have Type 2 Diabetes
- Are not currently pregnant
You will not qualify if you...
- Younger than 18 years of age
- Does not self-identify as Ojibwe/Anishinaabe/Chippewa
- Does not self-report using any kind of substances in the past 30 days
- Has history of head injury with loss of consciousness
- Has Type 2 Diabetes
- Has a seizure disorder
- Currently pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Great Lakes Hub
Duluth, Minnesota, United States, 55812
Actively Recruiting
Research Team
M
Miigis B Gonzalez, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here